Hematocrit and risk of venous thromboembolism in a general population. The Tromso study - Wikidata - awgldk - TriplyDB

Hematocrit and risk of venous thromboembolism in a general population. The Tromso study

Hematocrit and risk of venous thromboembolism in a general population. The Tromso study

http://www.wikidata.org/entity/Q33632252

about

Hematologic variables and venous thrombosis: red cell distribution width and blood monocyte count are associated with an increased risk.Hematocrit and the risk of recurrent venous thrombosis: a prospective cohort study.Red cell distribution width and other red blood cell parameters in patients with cancer: association with risk of venous thromboembolism and mortality A local increase in red blood cell aggregation can trigger deep vein thrombosis: evidence based on quantitative cellular ultrasound imaging.Current and future treatment options for polycythemia vera.Higher blood hematocrit predicts hyperuricemia: a prospective study of 62,897 person-years of follow-up.Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment.Fibrinogen, red blood cells, and factor XIII in venous thrombosis.Dynamics of blood flow and thrombus formation in a multi-bypass microfluidic ladder network.Erythrocytosis Following Testosterone Therapy.Blood donation and testosterone replacement therapy.High hematocrit as a risk factor for venous thrombosis. Cause or innocent bystander?Role of red blood cells in the anemia-associated bleeding under high shear conditions.New findings on venous thrombogenesis.Red blood cells in thrombosis.A hospital based retrospective study of factors influencing therapeutic leukapheresis in patients presenting with hyperleukocytic leukaemia.Evaluating the Potential of Routine Blood Tests to Identify the Risk of Deep Vein Thrombosis: A 1-Year Monocenter Cohort Study.Hemoglobin, Albuminuria, and Kidney Function in Cardiovascular Risk: The ARIC (Atherosclerosis Risk in Communities) Study.Testosterone use causing erythrocytosis.Platelets Drive Thrombus Propagation in a Hematocrit and Glycoprotein VI-Dependent Manner in an In Vitro Venous Thrombosis Model.Resolution of mid-ventricular thrombus in a patient with heart failure and high hematocrit.Hematocrit and the incidence of stroke: a prospective, population-based cohort study

P2860

Q33558200-ACA36F0D-BAB1-44D2-8837-A16BC4201B7E Q34305696-631A7D93-B9D6-4C1C-B425-8A6A7ACB767D Q34408343-C41448E6-8168-4B56-9D1F-0B84D6F8B6B6 Q34630573-4ABC5FFA-31BE-4139-BF42-3B66A1889388 Q35572748-A7EA6A13-ECA0-4877-B7DE-1B1657F80147 Q36026612-49CF423D-E664-4F02-BA76-0298E16D74EC Q36460573-FD780F85-3A28-4F2B-8FE5-E7EA0B4EE09B Q38235739-B1BA0E25-FDE8-474B-BA3A-EE5E10E461F3 Q38543294-CFAF8186-4A18-4E4E-B995-0C2DD0BD8EAE Q38744641-D7AC0D7A-77AB-4699-9F12-D5AA7A0873A3 Q38773828-49FAE850-B130-4322-97B2-2326B35EDEF3 Q38984984-5B1B78FC-90A6-4F20-BE1A-8F85F3089CC0 Q42922568-9B20946C-31CF-4F3A-9410-CCD7F671B2A4 Q45867365-C2D74D6A-0411-4885-ADA8-185733D2A1E6 Q47938011-6A6883ED-45F3-4E6E-8602-4FEAA5D4F274 Q48003288-8AE9369D-B2AE-41C7-B0DD-F5295ECC83F4 Q48267537-259D1BCB-1CB7-43E8-BD89-D51AACB88E61 Q48468211-A7ED4869-7922-4745-9990-3E70E52E8A95 Q50059256-16049FCB-9074-47E6-8184-00069D4281BD Q50077340-03695528-2486-43A9-B952-07C5254002A3 Q50146003-219A89B1-F86E-4AC4-B3FA-97747751F6AE Q50229054-1694A4F6-1EAA-41D5-970A-6E03584527FF Q58694461-AB4A4D7B-A578-4903-B0E0-7002AEEFC9F1

P2860

Hematocrit and risk of venous thromboembolism in a general population. The Tromso study

http://www.wikidata.org/entity/Q33632252

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Hematocrit and risk of venous thromboembolism in a general population. The Tromso study

@ast

Hematocrit and risk of venous thromboembolism in a general population. The Tromso study

@en

type

label

Hematocrit and risk of venous thromboembolism in a general population. The Tromso study

@ast

Hematocrit and risk of venous thromboembolism in a general population. The Tromso study

@en

prefLabel

Hematocrit and risk of venous thromboembolism in a general population. The Tromso study

@ast

Hematocrit and risk of venous thromboembolism in a general population. The Tromso study

@en

P1433

Q33632252-4EE882DC-B199-4171-84F3-3A349994C7C2

P1476

Q33632252-555CBC3A-C25F-44F2-9D29-3118E1809FE7

P2093

Q33632252-6A9AD7B4-D252-434E-B171-4811C4ACBF3F

Q33632252-7F2A983D-E37B-4B3A-AED4-458C4CCB521F

Q33632252-83D35D5D-388D-4CE0-8ED1-0BD3E4EAD02B

Q33632252-9007EF74-0E71-496C-93DA-48FF20585B40

P2860

Q33632252-045E387B-D199-4C0A-A5E7-97612060D720

Q33632252-20540404-FD63-4EF4-B34E-5CC7C25807D6

Q33632252-23215169-95DA-4832-8A16-A726B4B79656

Q33632252-356BC509-32E5-41EC-951F-AEBBF8CB4D1D

Q33632252-362C3F74-084A-4831-B228-35D37D52ECCC

Q33632252-3DC6D55B-4005-4094-8CAF-B964F91216A9

Q33632252-4CBE771F-6EC9-4154-989C-5A85DFFC8193

Q33632252-615CDD00-7306-4110-9BEA-0A92E3EEC4CF

Q33632252-68FA10D0-1980-405C-B0DD-4D3FC4C98F72

Q33632252-876736C1-B403-4E85-A153-922D0AFBD531

P304

Q33632252-F418F9BE-54C2-48AB-8E67-8A8F19696C02

P31

Q33632252-69057463-E6E5-407B-82DF-A7D4612CE15A

P356

Q33632252-915C9E5C-97DA-41F6-8B81-89874BA1244C

P433

Q33632252-0D636F2C-1081-4EE4-9151-D3305487A2F7

P478

Q33632252-D97563D3-15A4-4051-B810-3A25CEED78E5

P50

Q33632252-D0F3BFE8-C865-4528-9A02-703948AAD250

P577

Q33632252-F9AEF370-FD10-47DF-9B4B-DB08FCA59FCA

P5875

Q33632252-A63CFDEA-10A4-41F4-BF08-67B0D4440358

P698

Q33632252-5D8222C6-61F5-4888-906E-BDAEC2FFFA94

P921

Q33632252-829ADC94-BFDA-450B-9E54-B564B99ED76C

P932

Q33632252-98E7C405-AF45-426B-9D92-C5AA9624DB1F

P356

HAEMATOL.2009.008417

P1433

P1476

Hematocrit and risk of venous thromboembolism in a general population. The Tromso study

@en

P2093

Ellisiv B Mathiesen

http://www.w3.org/2001/XMLSchema#string

John-Bjarne Hansen

http://www.w3.org/2001/XMLSchema#string

Sigrid K Braekkan

http://www.w3.org/2001/XMLSchema#string

Tom Wilsgaard

http://www.w3.org/2001/XMLSchema#string

P2860

Venous thrombosis: a multicausal disease.

Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment.

Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets.

Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis.

Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology.

Cardiovascular risk factors and venous thromboembolism: a meta-analysis.

The epidemiology of venous thromboembolism.

Venous thromboembolism: disease burden, outcomes and risk factors.

Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia.

Bleeding and thrombosis in the myeloproliferative disorders.

P304

270-275

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2009.008417

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

Inger Njølstad

P577

2009-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38014911

http://www.w3.org/2001/XMLSchema#string

P698

19833630

http://www.w3.org/2001/XMLSchema#string

P921

venous thromboembolism

P932

2817030

http://www.w3.org/2001/XMLSchema#string